Respiratory illness thrives in the winter. This year, cases have been high and continue to be quite present, but Michigan appears to be past the season’s highest peak. The blanket term “respiratory ...

At issue with Moderna's mRNA flu shot is communication from CBER to Moderna suggesting that the company’s vaccine be compared against a control shot designed more specifically for older people.

After the U.S. withdrew from the World Health Organization, it wasn't clear they would participate in this WHO-led meeting to determine the recipe for the next flu vaccine.

Moderna stock jumped more than 6% after the FDA agreed to review the drugmaker's first flu shot of the season, reversing ...

Deaconess reports a 53% spike in flu cases and a 13% rise in RSV. A local doctor breaks down who's most at risk and what to ...

Flu is nothing to fool around with if you're high risk ...

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute ...

The 2025-26 flu season could continue into spring with unusual persistence and high severity. A new H3N2 variant is causing ...

Flu season is not over yet, experts warn. Is there a second wave coming? Here's how to protect yourself as influenza keeps spreading.

This prompts a reassessment of the stock’s value to determine if this represents a genuine opportunity or a potential trap.

Texas is reporting high to very high levels of flu activity, and the Gulf Coast region continues to see steady cases well beyond the typical winter peak.

Patients with advanced cancer receiving influenza vaccination during immunotherapy had longer survival in a Swedish study, with no increase in immune-related toxicities.